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α-Synuclein (α-syn) is the principal component of Lewy bodies, the
pathophysiological hallmark of individuals affected by Parkinson
disease (PD). This neuropathologic form of α-syn contributes to PD
progression and propagation of α-syn assemblies between neu-
rons. The data we present here support the proteomic analysis
used to identify neuronal proteins that speciﬁcally interact with
extracellularly applied oligomeric or ﬁbrillar α-syn assemblies
(conditions 1 and 2, respectively) (doi: 10.15252/embj.201591397
[1]). α-syn assemblies and their cellular partner proteins were
pulled down from neuronal cell lysed shortly after exposure to
exogenous α-syn assemblies and the associated proteins were
identiﬁed by mass spectrometry using a shotgun proteomic-based
approach. We also performed experiments on pure cultures of
astrocytes to identify astrocyte-speciﬁc proteins interacting with
oligomeric or ﬁbrillar α-syn (conditions 3 and 4, respectively). For
each condition, proteins interacting selectively with α-syn assem-
blies were identiﬁed by comparison to proteins pulled-down from











A.N. Shrivastava et al. / Data in Brief 7 (2016) 221–228222database search and the peak lists have been deposited to the
ProteomeXchange Consortium database via the PRIDE partner
repository with the dataset identiﬁers PRIDE: PXD002256 to PRIDE:
PXD002263 and doi: 10.6019/PXD002256 to 10.6019/PXD002263.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaProteomic, Neurobiology, Neurodegenerative diseasesype of data Mass spectrometry data and tables with identiﬁed protein.
ow data was
acquiredTryptic peptides were analyzed by nanoLC-MS/MS using an EASY-nLC HPLC
system (Proxeon, Thermo) coupled to a LTQ-Orbitrap-velos (Thermo) mass
spectrometer. Data acquisitions were conducted in the data-dependent acqui-
sition mode.ata format .Raw ﬁles from the instrument, .dat peak list ﬁles, .mzid identiﬁcation result ﬁles
using MASCOTxperimental
factorsCultured primary cortical neurons and astrocytes were exposed for 10 min to
oligomeric or ﬁbrillar S-tagged a-syn.xperimental
featuresNeuronal or astrocyte partner proteins of a-syn oligomers and ﬁbrils were
puriﬁed with the a-syn assemblies on S-protein agarose beads. Proteins were
digested on S-protein agarose beads using trypsin. Tryptic peptides were ana-
lyzed by nanoLC-MS/MS. Proteins were identiﬁed in the SwissProt database with
MASCOT. Proteins interacting selectively with a-syn assemblies were identiﬁed
by comparison to controls neurons and astrocytes that were not exposed to a-
syn assemblies.ata source
locationNeuroscience Institute of Paris-Saclay, “Protein misfolding and aggregation in
Neurodegenerative Diseases” team, CNRS, Gif-sur-Yvette, France.ata accessibility Data are within this article. The mass spectrometry proteomic data (neurons and
astrocytes) have been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identiﬁers PRIDE: PXD002256 to
PRIDE: PXD002263 and DOI 10.6019/PXD002256 to 10.6019/PXD002263. The list
of identiﬁed proteins are presented in Supplementary Tables 1–4.Value of the data
 Data from a proteomic-based screen identify a list of proteins from neurons and astrocytes that
interact with extracellularly applied oligomeric or ﬁbrillar α-syn.
 The large dataset of proteins interacting with exogenous oligomeric and ﬁbrillar α-syn includes
several extracellularly exposed proteins, corresponding to transmembrane proteins, cell surface
proteins and secreted proteins.
 The list of extracellularly exposed partner proteins identiﬁes targets of exogenous α-syn assem-
blies, among which Naþ/Kþ ATPase subunit α3 is the only neuronal speciﬁc transmembrane
protein interacting with both oligomeric and ﬁbrillar α-syn.
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Fibrillar α-Synuclein (α-syn) is the principal component of Lewy bodies, the pathophysiological
hallmark of individuals affected by Parkinson disease (PD). This neuropathologic form of α-syn
contributes to PD progression and propagation of α-syn assemblies between neurons. The aim of this
study [1] was to identify membrane proteins interacting with extracellularly applied α-syn assemblies
and exposed at the surface of neurons using a proteomic-based approach (Fig. 1) [1]. Data from this
proteomic-based screen performed on neurons and astrocytes cultures give a list of neuronal and
astrocytic proteins that interact with extracellularly applied oligomeric or ﬁbrillar α-syn. Data mining
of this large dataset of proteins highlights extracellularly exposed proteins interacting with exogenous
oligomeric and/or ﬁbrillar α-syn.
2. Experimental design, materials and methods
2.1. Experimental design
The data we present here support this proteomic analysis performed to identify neuronal mem-
brane proteins that speciﬁcally interact with extracellularly applied oligomeric or ﬁbrillar α-synFig. 1. Experimental strategy for proteomic identiﬁcation of proteins interacting speciﬁcally with extracellularly applied oli-
gomeric and ﬁbrillar α-syn. Rat cortical neurons (left panel) or astrocytes (right panel) were incubated for 10 min with oli-
gomeric or ﬁbrillar α-syn-S-tag (at a particle concentration of 1 mM and 4.8 nM, respectively, equivalent to 40 mMmonomeric α-
syn). After cell lysis, fresh protein extracts from those cells were incubated with S-protein agarose beads to pull down α-syn-S-
tag assemblies together with their speciﬁc protein partners. Unexposed cell extracts incubated with S-protein agarose beads
were used as a control. Proteins bound to the S-protein agarose beads were subjected to trypsin digestion and subsequently
identiﬁed and quantiﬁed by nanoLC-MS/MS analysis, using a nanoLC-LTQ-Orbitrap. The complete list of identiﬁed proteins is
shown in Supplementary Tables 1–4. Our data mining analysis highlighted a list of interacting protein partners of oligomeric
(blue frame) or ﬁbrillar α-syn (orange frame) described as extracellularly exposed in peer-reviewed articles: in blue trans-
membrane proteins with extracellular domains, in green proteoglycans and in black proteins that can be secreted or extra-
cellularly localized.
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S-tag that binds with high afﬁnity to ribonuclease S-protein [2] were used to identify speciﬁc partners
of extracellularly applied α-syn in neuronal cells. Two weeks old pure cultures of cortical neurons
were exposed to oligomeric or ﬁbrillar S-tagged α-syn for 10 min (conditions 1 and 2 respectively). α-
syn-S-tag assemblies and associated proteins were pulled down from whole-cell lysates using S-
protein agarose beads, trypsin digested, and the resulting peptides were identiﬁed by nanoLC-MS/MS.
Control samples were prepared for each condition from neurons unexposed to α-syn. Protein abun-
dance was assessed by a label-free quantitative proteomic method using spectral counting. From
whole neuron lysates, we identiﬁed 32 and 178 protein partners for oligomeric and ﬁbrillar α-syn,
respectively (Supplementary Tables 1 and 2). Several intracellular proteins were identiﬁed in the
screen due to the interaction of α-syn with cytosolic partners following their endocytosis [3–5] and/or
interaction following cell disruption during protein extraction. As pure cultures of neurons were
maintained in astrocyte-conditioned neuronal medium and in order to discriminate between astro-
cyte and neuron speciﬁc proteins, we made a control Pull down/MS experiment in which pure cul-
tures of astrocytes were exposed to oligomeric and ﬁbrillar S-tag α-syn (conditions 3 and 4 respec-
tively). From whole astrocyte lysates, we identiﬁed 25 and 108 protein partners for oligomeric and
ﬁbrillar α-syn, respectively (Supplementary Tables 3 and 4 respectively). The list of extracellularly
exposed partner proteins identiﬁed targets of exogenous α-syn assemblies, among which Naþ/Kþ
ATPase subunit α3 was the only neuronal speciﬁc transmembrane protein interacting with both
oligomeric and ﬁbrillar α-syn (Fig. 1). The proteomic data have been deposited to the Proteo-
meXchange Consortium database [6] via the PRIDE partner repository with the dataset identiﬁers
PRIDE:PXD002256 to PRIDE:PXD002263, and are associated with a research article published in
EMBO J [1].2.2. Preparation and characterization of α-syn-S-tag assemblies
C-terminally S-tagged (α-syn-S-tag) human α-syn was expressed and puriﬁed as described pre-
viously [7]. α-syn concentration was determined spectrophotometrically using an extinction coefﬁ-
cient of 5960 M1cm1 at 280 nm. Pure monomeric α-syn (0.2–0.5 mM) in 50 mM Tris–HCl, pH 7.5,
150 mM KCl was ﬁltered through sterile 0.22 mm ﬁlters and stored at 80 °C. For oligomers and ﬁbrils
formation, monomeric α-syn in buffer A were incubated at 4 °C for 7 days or 37 °C for 4 days under
continuous shaking in a thermomixer (Eppendorf, Germany) set at 600 rpm, respectively. Assembly
into ﬁbrils was monitored using Thioﬂavin T binding. Aliquots (10 ml) were withdrawn at different
time intervals from the assembly reaction and mixed with 400 ml of Thioﬂavin T (10 mM) in water and
Thioﬂavin T ﬂuorescence (Excitation wavelength: 440 nm and emission wavelength: 480 nm) was
recorded using a Cary Eclipse Spectroﬂuorometer (Varian Inc., Palo Alto, USA). Oligomeric α-syn was
separated from monomeric α-syn by size exclusion chromatography using a Superose
s
6 HR10/30
column (GE Healthcare) equilibrated in phosphate buffered saline (PBS) buffer. Fibrillar α-syn was
separated from monomeric α-syn through 2-cycles of sedimentation at 15,000g and re-suspension of
the pellet.
The nature of all α-syn assemblies used was assessed using a Jeol 1400 (Jeol Ltd., Peabody, MA)
Transmission Electron Microscope (TEM) after adsorption of the samples onto carbon-coated 200-
mesh grids and negative staining with 1% uranyl acetate. The images were acquired with a GatanOrius
CCD camera (Gatan). The particle concentration of oligomeric and ﬁbrillar α-syn samples was
assessed by analytical ultracentrifugation (AUC) and quantitative transmission electron microscopy
(TEM) as previously described [8]. The particle concentration of α-syn (tagged and untagged) was
obtained by dividing α-syn monomeric concentration by the average number of molecules (as
measured by AUC and TEM). For our preparation, the average number of molecules measured for
oligomeric and ﬁbrillar α-syn was 40 and 8333, respectively. The particles concentrations for oligo-
meric α-syn was 25 nM and that for ﬁbrillar α-syn was 0.03 nM, unless speciﬁed, corresponding to
1 mM or 0.25 mM monomeric α-syn, respectively.
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All cultures were prepared from 18-day-old Sprague-Dawley rat embryos (Janvier Labs, France).
Pull down and proteomic studies were performed on two weeks old pure cultures of rat cortical
neurons (DIV14) plated on 10 cm plates pre-coated with 80 mg/ml poly-D,L-ornithine. Cortical neu-
rons were used, as they can be prepared in larger quantities (4106 cells/dish) as required for these
proteomic experiments. Freshly dissociated (trypsin) cortices were plated (4106 cells per 10 cm
dish) in neuronal attachment media consisting of 10% horse serum, 1 mM sodium pyruvate (Life
Technologies), and 2 mM glutamine (Life Technologies) in minimum essential medium (MEM) (Life
Technologies) for 3 h. Pure neuronal cultures were maintained in astrocyte-conditioned neuronal
medium (see below) supplemented with cytosine-arabinoside (5 mM) as recently described [9].
Primary astrocyte cultures from rat cortex were prepared as described recently [9]. The culture
medium consisted of MEM supplemented with fetal bovine serum (10%, PAA Labs), sodium pyruvate
(1 mM), glutamine (2 mM), and penicillin/streptomycin (Life Technologies). The medium was
replaced after 24 h with fresh media.
Astrocyte cultures for feeding pure neurons: Astrocytes were plated and cultured in 10 cm dishes
as described above. At 10 DIV, cytosine-arabinoside containing media was added for 48 h. The
medium was then replaced with neuronal media containing: neurobasal medium, penicillin/strep-
tomycin, B27 (13, Life Technologies), glutamine (2 mM), and horse serum (5%, PAA Labs). Every other
day, this astrocyte-conditioned medium was used to feed neurons, and fresh neuronal medium was
added to the astrocyte cultures [9].
Recombinant oligomeric or ﬁbrillar α-syn-S-tag (40 mM monomer concentration) were added to
the culture medium of 2 weeks old pure cortical neuron cultures of rat (conditions 1 and 2 respec-
tively; 3–4 culture dishes per condition). For each condition, unexposed neurons were used as con-
trol. After 10 minutes, cells were washed twice with 1X PBS and scraped on ice in 50 mM Hepes-KOH
(pH 7.5), 2 mM EDTA, 0.1% Triton X-100, supplemented with complete protease inhibitor cocktail
(Roche). The extracts were ﬂash frozen in liquid nitrogen and stored at 80 °C. In order to dis-
criminate between neuronal speciﬁc proteins and proteins from astrocytes, we made a control
experiment in which pure astrocytes were exposed to recombinant S-tag α-syn assemblies (oligo-
meric and ﬁbrillar forms in conditions 3 and 4 respectively). For each condition, control samples were
prepared from pure astroctyes unexposed to α-syn. Three experimental replicates were performed for
each condition and corresponding unexposed cell controls.
2.4. Pull down of α-syn-S-tag bound protein complexes and sample preparation for mass spectrometry.
Cell lysis was completed by sonication and the protein concentration in the extracts determined
using BCA assay kit (Thermo Scientiﬁc). To pull down oligomeric or ﬁbrillar α-syn-S-tag together with
their speciﬁc protein partners, 0.5 mg of total protein extracts were incubated with S-protein agarose
(200 ml settled resin) (Novagen) equilibrated in 500 ml binding buffer (20 mM Tris–HCl pH 7.5,
150 mM NaCl, 0.1% Triton X-100, Complete protease inhibitors) for 1 h at 4 °C under gentle agitation.
Extracts from control-unexposed neurons were also incubated with S-protein agarose beads and used
as control. After 3 washes with 5 ml binding buffer and 3 washes with 5 ml Triton-free binding buffer,
the resin was re-suspended in 400 ml of 50 mM ammonium bicarbonate pH 8 in the presence of 0.1%
RapiGest (Waters corporation, Milford, MA) and heated at 95 °C for 10 min. Proteins were then
reduced in the presence of 10 mM dithiotreitol (DTT) at 56 °C for 30 min and alkylated in 20 mM
iodoacetamide (Sigma) at room temperature in the dark for 45 min. Proteins bound to the S-protein
agarose beads were digested on the resin by incubating the samples overnight at 37 °C in the pre-
sence of 0.8 mg trypsin Promega Gold (Promega, Madison, WI). After digestion, the samples were
centrifuged for 10 min at 16,000g to discard the resins. Trypsin digestion and RapiGest treatment in
the supernatants were stopped by addition of 0.5% TFA and incubation at 37 °C for 45 min. The tryptic
peptide samples were spun for 10 min at 16,000g and the supernatants were stored at 80 °C for MS
analysis.
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For each pull down, 15 ml of tryptic peptide digests were analyzed by nanoLC-MS/MS using an
EASY-nLC II high performance liquid chromatography (HPLC) system (Proxeon, Thermo-Scientiﬁc,
Waltham, MA) coupled to the nanoelectrospray ion source of a Linear Ion Trap-OrbitrapVelos mass
spectrometer (Thermo Scientiﬁc). Peptide separation was performed on a reversed phase C18 nano
HPLC column (100 mm inner diameter, 5 mm C18 particles, 15 cm length, NTCC-360/100-5) from
Nikkyo Technos (Nikkyo Technos Co., Ltd., Tokyo, Japan). The peptides were loaded at a pressure-
dependent ﬂow rate corresponding to a maximum pressure of 200 bars and eluted at a ﬂow rate of
300 nl/min using a two slope gradient of ﬁrst 5 to 20% solvent B for 60 min, followed by 20% to 40%
solvent B in 40 min and a washing step at 100% solvent B. Solvent A was 0.1% formic acid in water, and
solvent B was 0.1% formic acid in 100% acetonitrile. NanoLC-MS/MS experiments were conducted in
the data-dependent acquisition mode. The mass of the precursors was measured with a high reso-
lution (60,000 full weight at half maximum) in the Orbitrap. The 20 most intense ions, above an
intensity threshold of 5000 counts, were selected for CID fragmentation and analysis in the LTQ.
2.6. Data analysis
NanoLC-MS/MS raw data were processed automatically using the Scaffold software (version 3.6.4)
and the SwissProt_18112011 database with both the Mascot [10] (Version: 2.3.02) and the X! Tandem
[11] (Version CYCLONE 2010.12.01.1) search engine, a speciﬁc trypsin digestion with up to 2 missed
cleavages, a tolerance of 0.5 Da for fragment monoisotopic masses and 6 ppm for parent monoisotopic
mass tolerance, and the following chemical modiﬁcations: carbamidomethylation of Cys as ﬁxed
modiﬁcation, and dehydration, ammonia loss, oxidation of methionine and N-acetylation as variable
modiﬁcations. Scaffold (version Scaffold_3.6.4, Proteome Software Inc., Portland, OR) was used to
validate MS/MS based peptide and protein identiﬁcations. Peptide identiﬁcations were accepted if
they could be established at greater than 90.0% probability as speciﬁed by the Peptide Prophet
algorithm [12]. Protein identiﬁcations were accepted if they could be established at greater than 99.0%
probability and contained at least 2 identiﬁed peptides. Protein probabilities were assigned by the
Protein Prophet algorithm [13]. Proteins that contained similar peptides and could not be differ-
entiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
Identiﬁed proteins were quantiﬁed by a label-free proteomic approach using spectral counting [14]
with the Scaffold software. Comparison between controls and samples identiﬁed some proteins as
60S ribosomal proteins, nucleolin and ribonuclease inhibitor as major contaminants. Among them
nucleolin presented the best reproducibility among experiments and was chosen to normalize the
spectral counting data. Only proteins identiﬁed with at least 2 unique peptides in at least 2 replicates
were quantiﬁed. Only proteins with a spectral count ratio, between the cells exposed to α-syn (either
oligomeric or ﬁbrillar) and the control cells, above 1.6 and a p-valueo0.05 were considered as sig-
niﬁcantly increased in the pull down and thus considered as α-syn interacting proteins. Spectral count
ratios presented in Supplementary Tables 1–4 were calculated from averaged spectral counts of three
independent replicates.
Several intracellular proteins were identiﬁed in the screen due to the interaction following
endocytosis of α-syn assemblies [3–5] and/or interaction following cell disruption during protein
extraction and processing. Among the identiﬁed candidates, we picked the proteins annotated as cell
components of membrane, plasma membrane and/or extracellular regions, using the NCBI (National
Center for Biotechnology Information) annotation tool of the Scaffold software based on Gene
Ontology (GO) cell component term annotations [15] (Supplementary Tables 1–4). With this list of
proteins, we performed a second search in Pubmed in order to select proteins for which we found an
experimental description of extracellular exposure in peer-reviewed publications [16-31] (Supple-
mentary Tables 1–4). Only these latter proteins extracellularly exposed are reported in Fig. 1. This pull
down data mining analysis identiﬁed several targets of exogenous assemblies α-syn, and indicated
that Naþ/Kþ ATPase subunit α3 is the only transmembrane protein of our list with extracellularly
exposed domains that was identiﬁed both with oligomeric and ﬁbrillar α-syn (Fig. 1).
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The mass spectrometry proteomic data (neurons and astrocytes) have been deposited to the
ProteomeXchange Consortium [6] via the PRIDE partner repository with the dataset identiﬁers
PXD002256 through PXD002263 and DOI 10.6019/PXD002256 through 10.6019/PXD002263.Acknowledgments
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